Global Single-cell Analysis Market- by End-User Industry and By Application Forecast To 2022

The single-cell analysis market is expected to reach USD 3.59 Billion by 2022 from USD 1.67 Billion in 2017, at a CAGR of 16.5%.

According to the new market research report “Single-cell Analysis Market by Product (Consumables and Instruments), Cell Type (Human and Animal), Technique (Flow Cytometry, NGS, PCR, and Mass Spectrometry), Application (Cancer, Neurology, NIPD, IVF, and CTCs), End User — Global Forecasts to 2022” published by MarketsandMarkets™.

Speak to our analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=171955254

The growth in this market is mainly driven by the technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases.

Consumables estimated to dominate the market in 2017

Based on the type of products, the single-cell analysis market is segmented into consumables and instruments. In 2017, the consumables segment is expected to dominate this market, primarily due to requirement of frequent and repeat purchase of these products as compared to instruments, which are considered as a one-time investment.

Browse and in-depth TOC on “Single-cell Analysis Market”.

107 — Tables

42 — Figures

175 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/single-cell-analysis-market-171955254.html

Single-cell analysis market : The objectives for this study are as follows

• To define, describe, and forecast the market on the basis of products, cell type, technique, application, end user, and region.
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
• To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
• To track and analyze competitive developments such as agreements, partnerships, collaborations, mergers & acquisitions, and expansions in the market

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsample.asp?id=171955254

The single-cell analysis market is highly competitive with the presence of major players. Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.), Agilent Technologies (U.S.), Abcam Plc (U.S.), NuGEN Technologies, Inc. (U.S.), LumaCyte (U.S.), PluriSelect Life Science UG & Co. KG (Germany), Sysmex Partec (U.S.), Bio-Techne Corporation (U.S.), Promega Corporation (U.S.), 10x Genomics (U.S.), WaferGen Bio-systems, Inc. (U.S.), Bruker (U.S.), and Fluxion Biosciences (U.S.) are companies operating in the single-cell analysis market.

Browse Adjacent Markets @ Biotechnology Market Research Reports &; Consulting